Literature DB >> 17611579

PPAR and LXR activators regulate ABCA12 expression in human keratinocytes.

Yan J Jiang1, Biao Lu, Peggy Kim, Gyorgy Paragh, Gerd Schmitz, Peter M Elias, Kenneth R Feingold.   

Abstract

ATP-binding cassette (ABC) transporter, family 12 (ABCA12), a member of the ABC superfamily, facilitates the delivery of lipids to lamellar bodies (LB) in keratinocytes, which is critical for permeability barrier function. Recently, gene mutations of ABCA12 were found to underlie Harlequin ichthyosis and lamellar ichthyosis, two devastating skin disorders. Previously we and others have demonstrated that peroxisome proliferators-activated receptors (PPARs) and liver X receptor (LXR) activation improved epidermal permeability barrier homeostasis by stimulating keratinocyte differentiation, lipid synthesis, and increasing LB formation/secretion. Here we report that both PPAR-gamma and -beta/delta activators markedly stimulate ABCA12 mRNA expression in cultured human keratinocyte (CHK) in a dose- and time-dependent manner. Increased ABCA12 mRNA levels are accompanied by an increase in ABCA12 protein, suggesting biological importance of this upregulation. LXR activators also increase ABCA12 mRNA levels in CHK, but to a lesser extent. In contrast, activators of PPAR-alpha, RAR, RXR, or vitamin D receptor did not alter ABCA12 expression. Two major ABCA12 alternative transcripts and their corresponding proteins are also expressed and upregulated by PPAR or LXR activator in both undifferentiated and differentiated CHK. Together, our data demonstrate that PPAR and LXR activators increase ABCA12 expression, providing an additional mechanism by which PPAR and LXR activators promote epidermal permeability barrier homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611579     DOI: 10.1038/sj.jid.5700944

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  29 in total

Review 1.  Genetic pathways in disorders of epidermal differentiation.

Authors:  Vanessa Lopez-Pajares; Karen Yan; Brian J Zarnegar; Katherine L Jameson; Paul A Khavari
Journal:  Trends Genet       Date:  2012-11-08       Impact factor: 11.639

2.  Liver X receptor-retinoid X receptor (LXR-RXR) heterodimer cistrome reveals coordination of LXR and AP1 signaling in keratinocytes.

Authors:  Qi Shen; Yuchen Bai; Ken C N Chang; Yongjun Wang; Thomas P Burris; Leonard P Freedman; Catherine C Thompson; Sunil Nagpal
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

3.  Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders.

Authors:  Peter M Elias; Mary L Williams; Kenneth R Feingold
Journal:  Clin Dermatol       Date:  2012 May-Jun       Impact factor: 3.541

4.  The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation.

Authors:  Jennie Lugassy; Shelly Zaffryar-Eilot; Sharon Soueid; Amit Mordoviz; Victoria Smith; Ofra Kessler; Gera Neufeld
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

5.  Premature terminal differentiation and a reduction in specific proteases associated with loss of ABCA12 in Harlequin ichthyosis.

Authors:  Anna C Thomas; Daniel Tattersall; Elizabeth E Norgett; Edel A O'Toole; David P Kelsell
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

Review 6.  Pathogenesis-based therapies in ichthyoses.

Authors:  Joey E Lai-Cheong; Peter M Elias; Amy S Paller
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

7.  Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.

Authors:  Marianne Demerjian; Eung-Ho Choi; Mao-Qiang Man; Sandra Chang; Peter M Elias; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2009-02-19       Impact factor: 3.960

Review 8.  The outer frontier: the importance of lipid metabolism in the skin.

Authors:  Kenneth R Feingold
Journal:  J Lipid Res       Date:  2008-10-31       Impact factor: 5.922

9.  Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor {delta} in human keratinocytes.

Authors:  Yan J Jiang; Yoshikazu Uchida; Biao Lu; Peggy Kim; Cungui Mao; Masashi Akiyama; Peter M Elias; Walter M Holleran; Carl Grunfeld; Kenneth R Feingold
Journal:  J Biol Chem       Date:  2009-05-08       Impact factor: 5.157

10.  Troglitazone reverses the multiple drug resistance phenotype in cancer cells.

Authors:  Gerald F Davies; Bernhard H J Juurlink; Troy A A Harkness
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.